Skip to main content

ScienceDex / Researcher record

Sedivy, John M

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #1,176
  • Sustained Excellence
  • Program Leader
  • R01 Holder
  • Long-Funded
  • Top 10% Funded

NIH Funding · FY2023

$3.9M
Full award amounts, FY2023
2
Records listing this PI
#1,176
By linked amount among FY2023 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$801,7813#6,898
2007$282,4661#25,040
2008$276,4791#25,432
2009$845,5523#9,702
2010$861,8903#9,757
2011$624,3272#12,352
2012$406,3042#18,519
2013$479,2042#15,548
2014$515,6052#14,933
2015$557,5293#14,122
2016$2,542,6263#1,850
2017$2,649,1194#1,663
2018$2,883,2474#1,513
2019$2,487,4793#2,212
2020$2,694,8833#534
2021$810,4902#12,004
2022$3,923,6452#1,108
2023$3,853,3862#1,176

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20063 records
  2. FY20071 record
  3. FY20081 record
  4. FY20093 records
  5. FY20103 records
  6. FY20112 records
  7. FY20122 records
  8. FY20132 records
  9. FY20142 records
  10. FY20153 records
  11. FY20163 records
  12. FY20174 records
  13. FY20184 records
  14. FY20193 records
  15. FY20203 records
  16. FY20212 records
  17. FY20222 records
  18. FY2023 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Sedivy, John M. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2027 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award categories

  • Biochemistry

FY2023 award records by amount

NIH award records listing Sedivy, John M as a PI. Multi-PI records show the full award amount for context.

  • 5P01AG051449-07P01Contact PI
    Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease
    $3.2M
    award amount
  • 5R01AG016694-24R01Contact PI
    Effectors of Cellular Senescence States
    Brown University · Biochemistry (NIH department code)
    $613.5K
    award amount

Award organization

Organizations that administered FY2023 awards listing Sedivy, John M as a PI.

FY2023 award administered by Brown University (RI).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Brown University
  2. 2006
    $500K Cumulative Funding
  3. 2006
    Entered Top 50% Nationally
    Ranked #6898
  4. 2007
    $1M Cumulative Funding
  5. 2009
    $2M Cumulative Funding
  6. 2012
    R01 Grant Holder
  7. 2014
    $5M Cumulative Funding
  8. 2015
    Program/Center Grant Leader
  9. 2016
    Entered Top 25% Nationally
    Ranked #1850
  10. 2016
    Entered Top 10% Nationally
    Ranked #1850
  11. 2017
    $10M Cumulative Funding
  12. 2020
    Entered Top 5% Nationally
    Ranked #534
  13. 2023
    $25M Cumulative Funding